Showing results (11-20 of 158) with videos related to
Sort By:
Pageof 16
Journal of Medicinal Chemistry|June 19, 2018
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX InhibitorsSilvia Salerno, Elisabetta Barresi, Giorgio Amendola, et al.Journal of Chemical Information and Modeling|September 14, 2024
Discovering Dually Active Anti-cancer Compounds with a Hybrid AI-structure-based ApproachMichele Roggia, Benito Natale, Giorgio Amendola, et al.Biochimica Et Biophysica Acta. General Subjects|November 13, 2016
Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?Jussara Amato, Alessia Pagano, Sandro Cosconati, et al.Journal of Medicinal Chemistry|April 2, 2005
Architecture of the human urotensin II receptor: comparison of the binding domains of peptide and non-peptide urotensin II agonistsAntonio Lavecchia, Sandro Cosconati, Ettore NovellinoJournal of Chemical Information and Modeling|March 30, 2021
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual ScreeningGiorgio Amendola, Roberta Ettari, Santo Previti, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 21, 2019
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studiesCiro Milite, Giorgio Amendola, Alessio Nocentini, et al.Nature Structural & Molecular Biology|December 6, 2016
A balance between elongation and trimming regulates telomere stability in stem cellsTeresa Rivera, Candy Haggblom, Sandro Cosconati, et al.Journal of Medicinal Chemistry|March 6, 2007
Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculationsSandro Cosconati, Luciana Marinelli, Antonio Lavecchia, et al.Chemmedchem|August 8, 2006
Modeling of Cdc25B dual specifity protein phosphatase inhibitors: docking of ligands and enzymatic inhibition mechanismAntonio Lavecchia, Sandro Cosconati, Vittorio Limongelli, et al.Journal of Medicinal Chemistry|February 13, 2019
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal StructureCiro Milite, Alessandra Feoli, John R Horton, et al.Pageof 16